SAPIENCE THERAPEUTICS

sapience-therapeutics-logo

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme (GBM), which is the most severe and deadly form of brain cancer. The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.

#SimilarOrganizations #People #Financial #Website #More

SAPIENCE THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Therapeutics

Founded:
2015-01-01

Address:
Scarsdale, New York, United States

Country:
United States

Website Url:
http://www.sapiencetherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
914-607-6931

Total Funding:
71.51 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Euro Microsoft Exchange Online


Similar Organizations

sagimet-biosciences-logo

Sagimet Biosciences

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kinaset-therapeutics-logo

Kinaset Therapeutics

Kinaset Therapeutics is a therapeutics company that focuses on advancement of novel drugs in areas of unmet medical needs.

lineage-cell-therapeutics-logo

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

oncoheroes-biosciences-logo

Oncoheroes Biosciences

Oncoheroes Biosciences is a biotech company.

potenza-therapeutics-logo

Potenza Therapeutics

Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

tryp-therapeutics-logo

Tryp Therapeutics

Tryp Identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs.

larimar-therapeutics-logo

Larimar Therapeutics

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

Current Employees Featured

barry-kappel_image

Barry Kappel
Barry Kappel Founder, President & CEO @ Sapience Therapeutics
Founder, President & CEO
2015-10-01

howard-pien_image

Howard Pien
Howard Pien Chairman @ Sapience Therapeutics
Chairman

not_available_image

Gene Merutka
Gene Merutka Head of CMC @ Sapience Therapeutics
Head of CMC
2017-01-01

Founder


barry-kappel_image

Barry Kappel

Investors List

kingdon-capital_image

Kingdon Capital

Kingdon Capital investment in Series B - Sapience Therapeutics

nexpoint-bd03_image

NexPoint

NexPoint investment in Series B - Sapience Therapeutics

bristol-myers-squibb_image

Bristol Myers Squibb

Bristol Myers Squibb investment in Series B - Sapience Therapeutics

eshelman-ventures_image

Eshelman Ventures

Eshelman Ventures investment in Series B - Sapience Therapeutics

nexpoint-bd03_image

NexPoint

NexPoint investment in Convertible Note - Sapience Therapeutics

national-institute-of-allergy-and-infectious-diseases_image

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases investment in Grant - Sapience Therapeutics

connectivity-capital_image

Connectivity Ventures Fund

Connectivity Ventures Fund investment in Venture Round - Sapience Therapeutics

taian-technologies_image

TaiAn Technologies

TaiAn Technologies investment in Series A - Sapience Therapeutics

healthlink-capital_image

Healthlink Capital

Healthlink Capital investment in Series A - Sapience Therapeutics

eshelman-ventures_image

Eshelman Ventures

Eshelman Ventures investment in Series A - Sapience Therapeutics

Official Site Inspections

http://www.sapiencetherapeutics.com Semrush global rank: 4.88 M Semrush visits lastest month: 1.8 K

  • Host name: 228.98.139.34.bc.googleusercontent.com
  • IP address: 34.139.98.228
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Sapience Therapeutics" on Search Engine